Camber Capital Management

Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ALXN, CHNG, MYL, GSK, UHS, and represent 36.99% of Camber Capital Management's stock portfolio.
  • Added to shares of these 10 stocks: CHNG (+$129.87M), GSK (+$113.67M), ABBV (+$91.43M), ALXN (+$69.59M), VTR (+$67.00M), UHS (+$61.92M), HCA (+$40.43M), COLL (+$32.66M), ALKS (+$27.76M), INCY (+$26.40M).
  • Started 8 new stock positions in PBYI, INCY, GSK, COLL, PACB, ABBV, CHNG, NUVA.
  • Reduced shares in these 10 stocks: Allergan (-$191.17M), GILD (-$97.47M), , Synthorx Inc (-$69.89M), GBT (-$58.03M), BIIB (-$47.46M), MYL (-$38.09M), MNTA (-$34.00M), , TEVA (-$19.60M).
  • Sold out of its positions in DVA, GILD, GBT, MD, Synthorx Inc, TEVA, Allergan.
  • Camber Capital Management was a net buyer of stock by $82.44M.
  • Camber Capital Management has $1.67B in assets under management (AUM), dropping by -14.78%.

Portfolio Holdings for Camber Capital Management

Companies in the Camber Capital Management portfolio as of the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Alexion Pharmaceuticals (ALXN) 8.85 1.65M +88% 89.79
Change Healthcare Inc (CHNG) 7.76 13.00M NEW 9.99
Mylan Nv (MYL) 6.94 7.79M -24% 14.91
GlaxoSmithKline (GSK) 6.79 3.00M NEW 37.89
Universal Health Services (UHS) 6.66 1.12M +125% 99.08
Perrigo Company (PRGO) 5.74 2.00M +17% 48.09
Abbvie (ABBV) 5.46 1.20M NEW 76.19
Alkermes Plc (ALKS) 5.21 6.05M +46% 14.42
Ventas (VTR) 5.20 3.25M +333% 26.80
HCA HOLDINGS Inc (HCA) 4.56 850.00k +112% 89.85
Sarepta Therapeutics (SRPT) 4.23 725.00k +20% 97.82
Biogen Idec (BIIB) 3.78 200.00k -42% 316.38
Ascendis Pharma A S (ASND) 3.61 536.71k -19% 112.61
Momenta Pharmaceuticals (MNTA) 3.25 2.00M -38% 27.20
Nektar Therapeutics (NKTR) 3.20 3.00M -20% 17.85
Brookdale Senior Living (BKD) 3.17 17.00M +36% 3.12
Tenet Healthcare Corporation stock (THC) 3.01 3.50M +40% 14.40
Myriad Genetics (MYGN) 2.01 2.35M +135% 14.31
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 1.95 2.00M NEW 16.33
AMAG Pharmaceuticals (AMAG) 1.62 4.39M 6.18
Incyte Corporation (INCY) 1.58 360.46k NEW 73.23
Avrobio Ord (AVRO) 1.25 1.35M +125% 15.56
Translate Bio Inc (TBIO) 1.05 1.76M +17% 9.97
Puma Biotechnology Inc Common Stock (PBYI) 0.98 1.95M NEW 8.44
Atara Biotherapeutics (ATRA) 0.75 1.48M -49% 8.51
Glycomimetics (GLYC) 0.48 3.50M 2.28
Pacific Biosciences of California (PACB) 0.46 2.50M NEW 3.06
Sutro Biopharma Inc (STRO) 0.37 600.00k 10.20
NuVasive (NUVA) 0.10 33.63k NEW 50.67

Past Filings by Camber Capital Management

View past SEC 13F filings by Camber Capital Management

View all filings